1. Home
  2. WRN vs AMRN Comparison

WRN vs AMRN Comparison

Compare WRN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRN
  • AMRN
  • Stock Information
  • Founded
  • WRN 2006
  • AMRN 1989
  • Country
  • WRN Canada
  • AMRN Ireland
  • Employees
  • WRN N/A
  • AMRN N/A
  • Industry
  • WRN Metal Mining
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRN Basic Materials
  • AMRN Health Care
  • Exchange
  • WRN Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • WRN 228.0M
  • AMRN 216.0M
  • IPO Year
  • WRN N/A
  • AMRN 1993
  • Fundamental
  • Price
  • WRN $1.24
  • AMRN $16.40
  • Analyst Decision
  • WRN Strong Buy
  • AMRN Strong Sell
  • Analyst Count
  • WRN 1
  • AMRN 1
  • Target Price
  • WRN $4.00
  • AMRN $12.00
  • AVG Volume (30 Days)
  • WRN 344.1K
  • AMRN 189.4K
  • Earning Date
  • WRN 08-08-2025
  • AMRN 07-30-2025
  • Dividend Yield
  • WRN N/A
  • AMRN N/A
  • EPS Growth
  • WRN N/A
  • AMRN N/A
  • EPS
  • WRN N/A
  • AMRN N/A
  • Revenue
  • WRN N/A
  • AMRN $214,112,000.00
  • Revenue This Year
  • WRN N/A
  • AMRN N/A
  • Revenue Next Year
  • WRN N/A
  • AMRN $7.88
  • P/E Ratio
  • WRN N/A
  • AMRN N/A
  • Revenue Growth
  • WRN N/A
  • AMRN N/A
  • 52 Week Low
  • WRN $0.90
  • AMRN $7.08
  • 52 Week High
  • WRN $1.42
  • AMRN $17.18
  • Technical
  • Relative Strength Index (RSI)
  • WRN 50.93
  • AMRN 72.83
  • Support Level
  • WRN $1.18
  • AMRN $15.78
  • Resistance Level
  • WRN $1.26
  • AMRN $17.18
  • Average True Range (ATR)
  • WRN 0.06
  • AMRN 0.96
  • MACD
  • WRN -0.01
  • AMRN 0.21
  • Stochastic Oscillator
  • WRN 29.55
  • AMRN 86.99

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: